Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Nov 16, 2015

30339_dirs_2015-11-16_3cfd76a3-2117-48a0-bd4b-6fec8353b197.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-26

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-28 Common Stock M 6584.0000 $29.5550 Acquired 27488.5300 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-28 Stock Option (Right to Buy) $29.5550 M 6584.0000 Disposed 2023-02-19 Common Stock (6584.0000) Direct

Footnotes

F1: Acquisition through exercise of stock option erroneously omitted from original filing.

F2: Exercise erroneously omitted on original filing.